Back to Search
HECTOR NAVA, MD
MD
Surgery Physician
NPI: 1295726990Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
125198-1(NY)
Research & Publications (20)
Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia.
PMID 18996379·Gastroenterology·2009
4-observational
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.
PMID 19235592·Cancer Invest·2009
3-trial
Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.
PMID 18845990·Am J Clin Oncol·2008
3-trial
Chemical and mechanical bioerosion of boring sponges from Mexican Pacific coral reefs.
PMID 18723541·J Exp Biol·2008
4-observational
Malignant gastroparesis: pathogenesis and management of an underrecognized disorder.
PMID 17944143·J Support Oncol·2007
6-review
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
PMID 17643436·Gastrointest Endosc·2007
3-trial
The changing profile of esophageal cancer presentation and its implication for diagnosis.
PMID 17595930·J Natl Med Assoc·2007
8-other
Surgical management and outcome in primary adenocarcinoma of the small bowel.
PMID 17549572·Ann Surg Oncol·2007
4-observational
The introducer technique is the optimal method for placing percutaneous endoscopic gastrostomy tubes in head and neck cancer patients.
PMID 17180272·Surg Endosc·2007
8-other
Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.
PMID 17127229·J Chemother·2006
3-trial
Palliation of malignant dysphagia in esophageal cancer: a literature-based review.
PMID 17004508·J Support Oncol·2006
6-review
Management of locoregional stage esophageal cancer: a single center experience.
PMID 16643174·Dis Esophagus·2006
8-other
Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
PMID 16634075·Lasers Surg Med·2006
8-other
Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy.
PMID 16001178·Cancer Chemother Pharmacol·2006
3-trial
Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes.
PMID 16336612·Dis Esophagus·2005
4-observational
Cisplatin and gemcitabine for small cell carcinoma of the gall bladder.
PMID 16062088·Am J Clin Oncol·2005
5-case
Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?
PMID 15230725·Dis Esophagus·2004
8-other
Risk factors associated with earlier age of onset in familial pancreatic carcinoma.
PMID 15534880·Cancer·2004
8-other
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
PMID 12702566·Cancer Res·2003
8-other
Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas.
PMID 12417506·Ann Surg Oncol·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- ELM AND CARLTON ST
BUFFALO, NY 14263 - Phone
- (716) 845-2300
Quick Facts
- NPI
- 1295726990
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile